AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 259 filers reported holding AMICUS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,483 | +122.7% | 133,697 | +145.0% | 0.02% | +76.9% |
Q4 2022 | $666 | -99.4% | 54,577 | +333.9% | 0.01% | +550.0% |
Q3 2021 | $120,000 | -80.8% | 12,579 | -80.1% | 0.00% | -84.6% |
Q1 2021 | $625,000 | -41.3% | 63,292 | +37.2% | 0.01% | -56.7% |
Q4 2020 | $1,065,000 | +384.1% | 46,142 | +195.9% | 0.03% | +200.0% |
Q3 2020 | $220,000 | -54.1% | 15,596 | -68.3% | 0.01% | -52.4% |
Q4 2019 | $479,000 | +97.1% | 49,156 | +62.2% | 0.02% | +162.5% |
Q3 2019 | $243,000 | -91.0% | 30,305 | -86.1% | 0.01% | -89.6% |
Q2 2019 | $2,712,000 | +255.9% | 217,276 | +173.3% | 0.08% | +413.3% |
Q4 2018 | $762,000 | +72.4% | 79,495 | +117.2% | 0.02% | +36.4% |
Q3 2018 | $442,000 | -33.7% | 36,597 | -14.3% | 0.01% | -52.2% |
Q2 2018 | $667,000 | +437.9% | 42,724 | +246.4% | 0.02% | +475.0% |
Q2 2017 | $124,000 | -51.4% | 12,332 | -76.0% | 0.00% | -42.9% |
Q4 2016 | $255,000 | -35.9% | 51,290 | -29.7% | 0.01% | -12.5% |
Q2 2016 | $398,000 | +178.3% | 72,981 | +330.6% | 0.01% | +100.0% |
Q1 2016 | $143,000 | -73.6% | 16,950 | -56.2% | 0.00% | -77.8% |
Q3 2015 | $542,000 | -64.0% | 38,735 | -63.6% | 0.02% | -59.1% |
Q2 2015 | $1,505,000 | +1094.4% | 106,356 | +815.3% | 0.04% | +1000.0% |
Q1 2015 | $126,000 | -84.6% | 11,620 | -88.2% | 0.00% | -86.2% |
Q4 2014 | $820,000 | +76.3% | 98,522 | +26.2% | 0.03% | +70.6% |
Q3 2014 | $465,000 | – | 78,079 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |